What The Study Did: Researchers investigated the association between counties that adopted state mask mandates in Kansas with COVID-19 cases, hospitalizations and deaths.
A group of health care leaders, including a University of Massachusetts Amherst nurse innovator, has published a national call to action to prevent non-ventilator-associated, hospital-acquired pneumonia (NVHAP).
A blood gene profile associated with a high risk of dying from a severe lung disease can also predict poor outcomes in patients with COVID-19, a multicenter retrospective study led by the University of South Florida Health (USF Health) demonstrated. The risk profile based on 50 genes could help customize how COVID-19 is treated, improve allocation of limited health care resources such as intensive care beds and ventilators, and potentially save lives.
What The Study Did: Results of this study suggest race-specific disparities in SARS-CoV-2 testing and COVID-19 hospital outcomes seen in adults also exist among children, after accounting for several clinical and sociodemographic factors thought to play a role in the disease.
What The Study Did: This qualitative study reports that, in the midst of a major public health crisis, the erosion of family-centered care practices was associated with a dramatic impact on the experiences of family members of patients who died.
A study from Michigan Medicine reveals that Epic System's sepsis prediction tool performs much worse than indicated by the model's information sheet, correctly sorting patients on their risk of sepsis just 63 percent of the time.
In rare cases, adults who have recovered from COVID-19 may develop multisystem inflammatory syndrome, and clinicians should consider this possibility in adults with specific symptoms, as physicians describe in a case published in CMAJ (Canadian Medical Association Journal).
A signaling protein thought to be able to treat liver damage in paracetamol toxicity could actually worsen it. Instead, Singapore scientists discovered, blocking its effects could be the way forward.
A large, retrospective, multicenter study involving Washington University School of Medicine in St. Louis indicates that convalescent plasma from recovered COVID-19 patients can dramatically improve likelihood of survival among blood cancer patients hospitalized with the virus. The therapy involves transfusing plasma -- the pale yellow liquid in blood that is rich in antibodies -- from people who have recovered from COVID-19 into patients who have leukemia, lymphoma or other blood cancers and are hospitalized with the viral infection.
A study led by researchers at Washington University School of Medicine in St. Louis has identified a protein in the immune system that may protect babies from necrotizing enterocolitis, a leading cause of death among premature infants.